Patents by Inventor Yi Ru

Yi Ru has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260124289
    Abstract: The present disclosure belongs to the field of biotechnology, and specifically relates to a seven-component antigen African swine fever subunit vaccine. The present disclosure first provides an African swine fever virus antigen protein combination composed of the African swine fever virus P34 protein, P30 protein, P54 protein, A104R protein, C129R protein, X protein, and Y protein. This African swine fever virus antigen protein combination can induce a strong immune response in the host. Furthermore, the present disclosure provides a seven-component antigen African swine fever subunit vaccine including the aforementioned African swine fever virus antigen protein combination.
    Type: Application
    Filed: October 8, 2025
    Publication date: May 7, 2026
    Inventors: Haixue ZHENG, Yi RU, Huanan LIU, Jianhong GUO, Hong TIAN, Weijun CAO, Bingzhou LU, Fan YANG, Chaochao SHEN, Wei ZHANG, Yajun LI, Yang YANG, Zhengwang SHI, Jijun HE, Ye JIN, Dan LI, Zixiang ZHU, Ruoqing MAO, Rongzeng HAO, Guicai ZHANG, Wen DANG, Xusheng MA, Xiaodong QIN, Xiangtao LIU
  • Publication number: 20260124296
    Abstract: The present disclosure belongs to the field of biotechnology, and specifically relates to a nine-component antigen African swine fever subunit vaccine. The present disclosure first provides an African swine fever virus antigen protein combination composed of the African swine fever virus P34 protein, P30 protein, P54 protein, A104R protein, E165R protein, C129R protein, P72 protein, X protein, and Y protein. This African swine fever virus antigen protein combination can induce a strong immune response in the host. Furthermore, the present disclosure provides a nine-component antigen African swine fever subunit vaccine including the aforementioned African swine fever virus antigen protein combination.
    Type: Application
    Filed: October 9, 2025
    Publication date: May 7, 2026
    Inventors: Haixue ZHENG, Yi RU, Huanan LIU, Jianhong GUO, Hong TIAN, Weijun CAO, Bingzhou LU, Fan YANG, Chaochao SHEN, Wei ZHANG, Yajun LI, Yang YANG, Zhengwang SHI, Jijun HE, Ye JIN, Dan LI, Zixiang ZHU, Ruoqing MAO, Rongzeng HAO, Guicai ZHANG, Wen DANG, Xusheng MA, Xiaodong QIN, Xiangtao LIU
  • Publication number: 20250344360
    Abstract: A power converter that includes a housing and a power conversion circuit. A plurality of accommodation cavities separated from each other are disposed in the housing, and the plurality of accommodation cavities separated from each other include a first accommodation cavity, a second accommodation cavity, and a third accommodation cavity. The power conversion circuit includes a first electromagnetic compatibility module, a bus capacitor, and a second electromagnetic compatibility module. The first accommodation cavity is configured to accommodate the first electromagnetic compatibility module, the second accommodation cavity is configured to accommodate the bus capacitor, and the third accommodation cavity is configured to accommodate the second electromagnetic compatibility module. The first accommodation cavity and the third accommodation cavity are located on two sides of the second accommodation cavity. Accordingly, EMC of the power converter can be improved.
    Type: Application
    Filed: June 25, 2025
    Publication date: November 6, 2025
    Applicant: Huawei Digital Power Technologies Co., Ltd.
    Inventors: Hui Shi, Libin Hui, Tianqi Hu, Yi Ru, Zheng Ma
  • Publication number: 20250286365
    Abstract: A power conversion apparatus which includes a direct current end, a power conversion circuit, a direct current side protection circuit, a first alternating current side protection circuit, and an alternating current end. The direct current side protection circuit is connected between the direct current end and protective earthing (PE). A plurality of protection branches of the first alternating current side protection circuit are connected between the alternating current end and the PE, and are configured as: when an alternating current end voltage between the alternating current end and the PE is greater than a second threshold, at least one of the plurality of protection branches is in a conducted state, for the alternating current end voltage to be clamped at a second voltage value.
    Type: Application
    Filed: February 26, 2025
    Publication date: September 11, 2025
    Applicant: Huawei Digital Power Technologies Co., Ltd.
    Inventors: Luo LI, Yi RU, Sheng RAO
  • Patent number: 11987797
    Abstract: The present disclosure belongs to the technical field of biology, and in particular relates to an attenuated strain of African swine fever virus (ASFV) with IPTG-induced deletion of a D1133L gene and use thereof. In the present disclosure, it is firstly found that the D1133L protein of ASFV can inhibit production of IFN-? and downstream cytokines ISG-15 and ISG-56, and can be used as an immunosuppressant with a relatively strong immunosuppressive effect. In addition, the attenuated strain of ASFV with IPTG-induced deletion of the D1133L gene is constructed. Specifically, a screening expression cassette is inserted into a position before the non-structural protein gene D1133L of the ASFV using an Escherichia coli lac operator-repressor system, to obtain a recombinant virus. In the presence of the IPTG, the recombinant virus has similar characteristics to a wild-type virus; and in the absence of the IPTG, the expression of the D1133L protein is inhibited.
    Type: Grant
    Filed: November 21, 2022
    Date of Patent: May 21, 2024
    Assignee: LANZHOU VETERINARY RESEARCH INSTITUTE, CHINESE ACADEMY OF AGRICULTURAL SCIENCES
    Inventors: Haixue Zheng, Keshan Zhang, Ting Zhang, Tao Feng, Bo Yang, Xing Yang, Xijuan Shi, Hong Tian, Yi Ru, Fan Yang, Zixiang Zhu, Jianhong Guo, Jijun He, Xiangtao Liu
  • Patent number: 11883482
    Abstract: The disclosure provides a recombinant nucleic acid of Seneca valley virus, a recombinant vaccine strain and preparation method and use thereof, and relates to the technical field of genetic engineering. The disclosure provides the recombinant nucleic acid of Seneca valley virus, recombinant Seneca valley virus comprising the recombinant nucleic acid, recombinant Seneca valley virus encoded by the recombinant nucleic acid, recombinant Seneca valley virus vaccine strain comprising the recombinant Seneca valley virus and preparation method and use thereof. According to the disclosure, a vaccine strain characterized by high antigen production capacity, remarkably reduced pathogenicity (even having no pathogenicity to pigs), strong antibody induction activity, high immune protection rate is prepared. The vaccine strain remarkably improves the biological safety and can be used for preventing and controlling Seneca valley virus in China and the neighboring countries.
    Type: Grant
    Filed: May 24, 2021
    Date of Patent: January 30, 2024
    Inventors: Haixue Zheng, Fan Yang, Zixiang Zhu, Weijun Cao, Hong Tian, Keshan Zhang, Ting Wei, Min Zheng, Wei Zhang, Wen Dang, Xusheng Ma, Dan Li, Yi Ru, Jijun He, Jianhong Guo, Xiangtao Liu
  • Patent number: 11883411
    Abstract: The present disclosure belongs to the technical field of African swine fever (ASF) treatment, in particular to use of a compound aprepitant in prevention or treatment of the ASF. In the present disclosure, it is found that the compound aprepitant can significantly inhibit replication of an African swine fever virus (ASFV); in addition, it is found that the aprepitant inhibits transcription and protein expression of D1133L, and reduces transcription and protein expression levels of p30 and p72, preventing virus invasion on host cells. Therefore, the compound aprepitant can be used to inhibit early and late infection of the ASFV. Accordingly, the compound aprepitant can be used to prevent or treat the ASF.
    Type: Grant
    Filed: August 25, 2022
    Date of Patent: January 30, 2024
    Assignee: LANZHOU VETERINARY RESEARCH INSTITUTE, CHINESE ACADEMY OF AGRICULTURAL SCIENCES
    Inventors: Keshan Zhang, Haixue Zheng, Huimei Cui, Bo Yang, Hong Tian, Zixiang Zhu, Tao Feng, Fan Yang, Weijun Cao, Xusheng Ma, Yi Ru, Jianhong Guo, Xiangtao Liu
  • Publication number: 20230295641
    Abstract: The present disclosure belongs to the technical field of biology, and in particular relates to an attenuated strain of African swine fever virus (ASFV) with IPTG-induced deletion of a D1133L gene and use thereof. In the present disclosure, it is firstly found that the D1133L protein of ASFV can inhibit production of IFN-? and downstream cytokines ISG-15 and ISG-56, and can be used as an immunosuppressant with a relatively strong immunosuppressive effect. In addition, the attenuated strain of ASFV with IPTG-induced deletion of the D1133L gene is constructed. Specifically, a screening expression cassette is inserted into a position before the non-structural protein gene D1133L of the ASFV using an Escherichia coli lac operator-repressor system, to obtain a recombinant virus. In the presence of the IPTG, the recombinant virus has similar characteristics to a wild-type virus; and in the absence of the IPTG, the expression of the D1133L protein is inhibited.
    Type: Application
    Filed: November 21, 2022
    Publication date: September 21, 2023
    Applicant: LANZHOU VETERINARY RESEARCH INSTITUTE, CHINESE ACADEMY OF AGRICULTURAL SCIENCES
    Inventors: Haixue ZHENG, Keshan ZHANG, Ting ZHANG, Tao FENG, Bo YANG, Xing YANG, Xijuan SHI, Hong TIAN, Yi RU, Fan YANG, Zixiang ZHU, Jianhong GUO, Jijun HE, Xiangtao LIU
  • Publication number: 20230270747
    Abstract: The present disclosure belongs to the technical field of African swine fever (ASF) treatment, in particular to use of a compound aprepitant in prevention or treatment of the ASF. In the present disclosure, it is found that the compound aprepitant can significantly inhibit replication of an African swine fever virus (ASFV); in addition, it is found that the aprepitant inhibits transcription and protein expression of D1133L, and reduces transcription and protein expression levels of p30 and p72, preventing virus invasion on host cells. Therefore, the compound aprepitant can be used to inhibit early and late infection of the ASFV. Accordingly, the compound aprepitant can be used to prevent or treat the ASF.
    Type: Application
    Filed: August 25, 2022
    Publication date: August 31, 2023
    Applicant: LANZHOU VETERINARY RESEARCH INSTITUTE, CHINESE ACADEMY OF AGRICULTURAL SCIENCES
    Inventors: Keshan ZHANG, Haixue ZHENG, Huimei CUI, Bo YANG, Hong TIAN, Zixiang ZHU, Tao FENG, Fan YANG, Weijun CAO, Xusheng MA, Yi RU, Jianhong GUO, Xiangtao LIU
  • Patent number: 11386221
    Abstract: Embodiments allow, within database security policies, the grant of data change operation-specific privileges to particular users to be applied within particular data realms in a given table. Furthermore, according to one or more embodiments, User Privilege column-level privileges are explicitly associated with one or more data access operations such that the grant of such a column-level privilege allows the user to perform only those data access operations that are explicitly associated with the column-level privilege. Enforcement of the data security policies includes prevention of data leakage via WHERE and RETURNING INTO clauses. According to one or more embodiments, a two-phase rewrite is used to optimize enforcement of column-level privileges. During the two-phase rewrite of a given query, the privileges checked during enforcement of the User Privilege data security policies are pruned to avoid unnecessary privilege checks given the columns that are accessed in the query.
    Type: Grant
    Filed: April 15, 2019
    Date of Patent: July 12, 2022
    Assignee: ORACLE INTERNATIONAL CORPORATION
    Inventors: Tanvir Ahmed, Yi Ru, Chao Liang, Vikram Reddy Pesati
  • Publication number: 20220031832
    Abstract: The disclosure provides a recombinant nucleic acid of Seneca valley virus, a recombinant vaccine strain and preparation method and use thereof, and relates to the technical field of genetic engineering. The disclosure provides the recombinant nucleic acid of Seneca valley virus, recombinant Seneca valley virus comprising the recombinant nucleic acid, recombinant Seneca valley virus encoded by the recombinant nucleic acid, recombinant Seneca valley virus vaccine strain comprising the recombinant Seneca valley virus and preparation method and use thereof. According to the disclosure, a vaccine strain characterized by high antigen production capacity, remarkably reduced pathogenicity (even having no pathogenicity to pigs), strong antibody induction activity, high immune protection rate is prepared. The vaccine strain remarkably improves the biological safety and can be used for preventing and controlling Seneca valley virus in China and the neighboring countries.
    Type: Application
    Filed: May 24, 2021
    Publication date: February 3, 2022
    Applicant: Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences
    Inventors: Haixue Zheng, Fan Yang, Zixiang Zhu, Weijun Cao, Hong Tian, Keshan Zhang, Ting Wei, Min Zheng, Wei Zhang, Wen Dang, Xusheng Ma, Dan Li, Yi Ru, Jijun He, Jianhong Guo, Xiangtao Liu
  • Publication number: 20190243987
    Abstract: Embodiments allow, within database security policies, the grant of data change operation-specific privileges to particular users to be applied within particular data realms in a given table. Furthermore, according to one or more embodiments, User Privilege column-level privileges are explicitly associated with one or more data access operations such that the grant of such a column-level privilege allows the user to perform only those data access operations that are explicitly associated with the column-level privilege. Enforcement of the data security policies includes prevention of data leakage via WHERE and RETURNING INTO clauses. According to one or more embodiments, a two-phase rewrite is used to optimize enforcement of column-level privileges. During the two-phase rewrite of a given query, the privileges checked during enforcement of the User Privilege data security policies are pruned to avoid unnecessary privilege checks given the columns that are accessed in the query.
    Type: Application
    Filed: April 15, 2019
    Publication date: August 8, 2019
    Inventors: Tanvir Ahmed, Yi Ru, Chao Liang, Vikram Reddy Pesati
  • Patent number: 10303894
    Abstract: Embodiments allow, within database security policies, the grant of data change operation-specific privileges to particular users to be applied within particular data realms in a given table. Furthermore, according to one or more embodiments, User Privilege column-level privileges are explicitly associated with one or more data access operations such that the grant of such a column-level privilege allows the user to perform only those data access operations that are explicitly associated with the column-level privilege. Enforcement of the data security policies includes prevention of data leakage via WHERE and RETURNING INTO clauses. According to one or more embodiments, a two-phase rewrite is used to optimize enforcement of column-level privileges. During the two-phase rewrite of a given query, the privileges checked during enforcement of the User Privilege data security policies are pruned to avoid unnecessary privilege checks given the columns that are accessed in the query.
    Type: Grant
    Filed: August 31, 2016
    Date of Patent: May 28, 2019
    Assignee: Oracle International Corporation
    Inventors: Tanvir Ahmed, Yi Ru, Chao Liang, Vikram Reddy Pesati
  • Patent number: 10102355
    Abstract: Techniques for efficient cursor sharing to enforce fine-grained access control are provided. In one technique, the authorization context of a database statement is stored in (or in association with) a corresponding cursor. The authorization context indicates multiple authorization results, each of which indicates whether a user (or role) associated with the database statement is allowed to access a different data set of multiple data sets that the database statement targets. An authorization context of an incoming database statement may be compared to the authorization context of a cursor in a single comparison to determine whether the authorization contexts match. If so, then the cursor may be shared. In another technique, one or more normalizations are applied to a cursor predicate that is generated based on the authorization context of a database statement. The one or more normalizations may result in removing one or more predicates from the cursor predicate.
    Type: Grant
    Filed: June 24, 2014
    Date of Patent: October 16, 2018
    Assignee: Oracle International Corporation
    Inventors: Tanvir Ahmed, Yi Ru, Chao Liang, Vikram R. Pesati
  • Patent number: 10098166
    Abstract: A method includes: monitoring a plurality of wireless working frequency bands supported by a smart terminal; when a Peer to Peer (P2P) data packet is received at any of the wireless working frequency bands, analyzing the P2P data packet and obtaining device information of a smart device; and establishing a wireless connection with the smart device at the wireless working frequency band according to the device information.
    Type: Grant
    Filed: December 16, 2016
    Date of Patent: October 9, 2018
    Assignee: Xiaomi Inc.
    Inventors: Xin Liang, Yi Ru, Guizhou Wu
  • Publication number: 20180060603
    Abstract: Embodiments allow, within database security policies, the grant of data change operation-specific privileges to particular users to be applied within particular data realms in a given table. Furthermore, according to one or more embodiments, User Privilege column-level privileges are explicitly associated with one or more data access operations such that the grant of such a column-level privilege allows the user to perform only those data access operations that are explicitly associated with the column-level privilege. Enforcement of the data security policies includes prevention of data leakage via WHERE and RETURNING INTO clauses. According to one or more embodiments, a two-phase rewrite is used to optimize enforcement of column-level privileges. During the two-phase rewrite of a given query, the privileges checked during enforcement of the User Privilege data security policies are pruned to avoid unnecessary privilege checks given the columns that are accessed in the query.
    Type: Application
    Filed: August 31, 2016
    Publication date: March 1, 2018
    Inventors: Tanvir Ahmed, Yi Ru, Chao Liang, Vikram Reddy Pesati
  • Publication number: 20170188397
    Abstract: A method includes: monitoring a plurality of wireless working frequency bands supported by a smart terminal; when a Peer to Peer (P2P) data packet is received at any of the wireless working frequency bands, analyzing the P2P data packet and obtaining device information of a smart device; and establishing a wireless connection with the smart device at the wireless working frequency band according to the device information.
    Type: Application
    Filed: December 16, 2016
    Publication date: June 29, 2017
    Inventors: Xin LIANG, Yi RU, Guizhou WU
  • Patent number: 9693112
    Abstract: A remote control system for a video playback device, such as a smart television is provided herein. The system can obtain a playback task customized by a user via a server or a remote control device. The playback task can include at least a content file source. The server or remote control device can obtain playback instructions corresponding to the playback task and communicate the playback instructions to the playback device. The playback device can obtain a content file from the content file source via a residential gateway associated with the playback task after receiving the playback instructions, and then play the content file.
    Type: Grant
    Filed: May 14, 2015
    Date of Patent: June 27, 2017
    Assignee: Xiaomi Inc.
    Inventors: Huadong Liu, Jun Zhang, Yi Ru
  • Publication number: 20170078837
    Abstract: The present disclosure relates to methods and devices for locating a wearable device. The method includes: determining, by the wearable device, whether a first short range communication connection between the wearable device and a first terminal is disconnected; and when it is determined that the first short range communication connection is disconnected, broadcasting, by the wearable device, a notification message configured to instruct a second terminal to: establish a second short range communication connection with the wearable device, and send a connection notification to a server, wherein the server locates the wearable device according to the second terminal.
    Type: Application
    Filed: September 14, 2016
    Publication date: March 16, 2017
    Inventors: Xin LIANG, Kangxi TAN, Yi RU, Li HE
  • Patent number: D1104639
    Type: Grant
    Filed: June 7, 2024
    Date of Patent: December 9, 2025
    Inventor: Yi Ru